5 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34610548 | Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancer. | 2021 Dec 15 | 3 |
2 | 28296398 | Discovery of an Acrylic Acid Based Tetrahydroisoquinoline as an Orally Bioavailable Selective Estrogen Receptor Degrader for ERα+ Breast Cancer. | 2017 Apr 13 | 1 |
3 | 18272256 | Synthesis and preliminary biological evaluation of new carbon-11 labeled tetrahydroisoquinoline derivatives as SERM radioligands for PET imaging of ER expression in breast cancer. | 2008 Oct | 1 |
4 | 15686893 | QSAR of estrogen receptor modulators: exploring selectivity requirements for ER(alpha) versus ER(beta) binding of tetrahydroisoquinoline derivatives using E-state and physicochemical parameters. | 2005 Feb 15 | 2 |
5 | 12825935 | Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands. | 2003 Jul 3 | 1 |